CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The project seeks to develop new therapeutics for pancreatic ductal adenocarcinoma, a highly lethal cancer. It involves a multidisciplinary team to create and test novel drugs targeting cancer pathways and mechanisms of metastasis.
Pancreatic ductal adenocarcinoma (PDAC) causes 34000 deaths in the EU every year.
Conventional cancer treatments have close to no impact on this disease.
As a result, almost all patients diagnosed with PDAC develop metastases and eventually die.
Given this poor outlook, the search for new therapeutics is mandatory.
These will have to target relevant cancer pathways and be designed based on the available knowledge on the genetic alterations that characterize this malignancy.
We propose to build a…
UNIVERSITATSKLINIKUM BONN
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Italy, Genova
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Switzerland, Lausanne
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Switzerland, Lausanne
Type: Public body
Activity type: Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
